Introduction: Coronavirus disease 2019 (COVID-19) vaccines protect against severe illness. However, data on post-vaccination COVID-19 breakthrough infections are limited.Methods: An analytical cross-sectional study was conducted from May 2021 to July 2021 among 2043 COVID-19-positive healthcare workers who were divided into a vaccinated group (n=1010) and an unvaccinated group (n=1033). A pre-tested questionnaire was circulated among the healthcare workers using Google Forms. Chest computed tomography (CT) severity score was the primary outcome variable analyzed using coGuide.Results: The average age of the study population was less than 45 years in both groups (43.05 ± 13.02 years). Most respondents (62%) were males. Hypertension (39%) and diabetes (33%) were the most common underlying diseases. Significant differences in age and cardiac disease were observed between the two groups (p = 0.07 and p <0.001, respectively). However, the difference was insignificant (p >0.05) for gender, hypertension, and diabetes. Most unvaccinated respondents had an increased CT severity score, and the difference between the studies groups was significant (p <0.001). Of the 1,010 vaccinated individuals, 382 (37.82%) received the only first vaccination dose, and 628 (62.18%) received both doses. The CT severity score decreased after receiving both vaccination doses, and the difference between CT severity score and vaccination status was significant (p <0.001).Conclusion: COVID-19 was mild in the vaccinated group. Chest CT severity score index can be considered an efficient tool in predicting prognosis and monitoring disease in patients with COVID-19 in India.
To evaluate USG and CT imaging findings in differentiating transudative and exudative pleural effusion. Materials and methods: A prospective observational study was performed over a period of eighteen months between January 2016 and June 2017. Eighty patients with pleural effusion were included and were evaluated with USG and CT along with diagnostic thoracocentesis. USG appearances and CT attenuation values along with additional findings like presence of pleural thickening, pleural nodules and loculation were evaluated. Results: 24 (30%) were transudates and 56 (70%) were exudates. Transudative were always anechoic. Exudates were complex septated (62.5%), echogenic (25%) or complex non-septated (8.9%) on USG with very few being anechoic (3.5%). Loculations were better appreciated on ultrasound while pleural thickening and nodules were better seen on CT. Mean attenuation values were significantly higher in exudates (14.65 ± 6.07; mean ± SD, range: 4.5 to 34) than transudates (4.66 ± 2.29; mean ± SD, range: 1.3 to 8.2) with a P value <0.01. Effusions can be considered as transudative if the CT attenuation value is <8, with a sensitivity of 91.6% and specificity of 82.7% with a significant P value <0.01. Pleural thickening, nodules and loculations were seen commonly in exudates than transudates with a high specificity (91.6 %, 95.8% and 100% respectively). Conclusion: USG is a helpful non-invasive and bedside tool in determining the nature of pleural effusion. CT attenuation values play a useful role in differentiating the nature of pleural effusion. Transudative effusions can be considered when HU values are <8.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.